U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 1354

1.
Promotion of stem cell-like phenotype of lung adenocarcinoma by FAM83A via stabilization of ErbB2
Ye Yuan, Liang Hao, Jing-Shan Huang, Fu-Ying Zhao, Ying-Hua Ju, Jia-Mei Wang, Ting Zhang, Bai-Qiang Li, Zhan-Wu Yu
Cell Death Dis. 2024 Jun; 15(6): 460. Published online 2024 Jun 28. doi: 10.1038/s41419-024-06853-w
PMCID:
PMC11213963
AbstractArticlePDF–3.5M
2.
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations
Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, Satoshi Takahashi, Kazuma Kobayashi, Nobuji Kouno, Amina Bolatkan, Masaaki Komatsu, Masayoshi Yamada, Mototaka Miyake, Hirokazu Watanabe, Akiko Tateishi, Takaaki Mizuno, Yu Okubo, Masami Mukai, Tatsuya Yoshida, Yukihiro Yoshida, Hidehito Horinouchi, Shun-Ichi Watanabe, Yuichiro Ohe, Yasushi Yatabe, Vassiliki Saloura, Takashi Kohno, Ryuji Hamamoto
Mol Cancer. 2024; 23: 126. Published online 2024 Jun 11. doi: 10.1186/s12943-024-02035-6
PMCID:
PMC11165761
AbstractArticlePDF–2.7M
3.
Induction of ErbB2 by ultraviolet A irradiation: Potential role in malignant transformation of keratinocytes
Chang Yeob Han, Sung Chul Lim, Hong Seok Choi, Keon Wook Kang
Cancer Sci. 2008 Mar; 99(3): 502–509. Published online 2008 Jan 2. doi: 10.1111/j.1349-7006.2007.00718.x
PMCID:
PMC11159869
AbstractArticlePDF–259K
4.
Relationship between cyclooxygenase‐2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up‐regulation and lymphangiogenesis in human breast cancer
Rabindra N. Bhattacharjee, Alexander V. Timoshenko, Jing Cai, Peeyush K. Lala
Cancer Sci. 2010 Sep; 101(9): 2026–2032. Published online 2010 Jun 14. doi: 10.1111/j.1349-7006.2010.01647.x
Correction in:
Cancer Sci. 2010 Oct; 101(10): 2293.
PMCID:
PMC11159705
AbstractArticlePDF–775K
5.
HER2 overexpression correlates with survival after curative resection of pancreatic cancer
Masahiro Komoto, Bunzo Nakata, Ryosuke Amano, Nobuya Yamada, Masakazu Yashiro, Masaichi Ohira, Kenichi Wakasa, Kosei Hirakawa
Cancer Sci. 2009 Jul; 100(7): 1243–1247. Published online 2009 Mar 30. doi: 10.1111/j.1349-7006.2009.01176.x
PMCID:
PMC11159349
AbstractArticlePDF–877K
6.
Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients
Kentaro Tamaki, Hironobu Sasano, Takanori Ishida, Minoru Miyashita, Motohiro Takeda, Masakazu Amari, Nobumitsu Tamaki, Noriaki Ohuchi
Cancer Sci. 2010 Sep; 101(9): 2074–2079. Published online 2010 May 25. doi: 10.1111/j.1349-7006.2010.01630.x
PMCID:
PMC11158137
AbstractArticlePDF–173K
7.
Mechanisms of resistance to estrogen receptor modulators in ER+/HER2− advanced breast cancer
Jin Zhang, Qianying Wang, Qing Wang, Jiangran Cao, Jiafu Sun, Zhengmao Zhu
Cell Mol Life Sci. 2020 Feb; 77(4): 559–572. Published online 2019 Aug 30. doi: 10.1007/s00018-019-03281-4
PMCID:
PMC11105043
AbstractArticlePDF–808K
8.
Exercise-induced β2-adrenergic Receptor Activation Enhances the Antileukemic Activity of Expanded γδ T-Cells via DNAM-1 Upregulation and PVR/Nectin-2 Recognition
Forrest L. Baker, Kyle A. Smith, Preetesh L. Mylabathula, Tiffany M. Zúñiga, Douglass M. Diak, Helena Batatinha, Grace M. Niemiro, Michael D. Seckeler, Charles R. Pedlar, Daniel P. O'Connor, Jamie Colombo, Emmanuel Katsanis, Richard J. Simpson
Cancer Res Commun. 2024 May; 4(5): 1253–1267. Published online 2024 May 13. doi: 10.1158/2767-9764.CRC-23-0570
PMCID:
PMC11090081
AbstractArticlePDF–13M
9.
Regulatory T cells increase in breast cancer and in stage IV breast cancer
Zhi-kuan Wang, Bo Yang, Hui Liu, Yi Hu, Jun-lan Yang, Liang-liang Wu, Zhen-hong Zhou, Shun-chang Jiao
Cancer Immunol Immunother. 2012 Jun; 61(6): 911–916. Published online 2011 Nov 25. doi: 10.1007/s00262-011-1158-4
PMCID:
PMC11029076
AbstractArticlePDF–294K
10.
Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer
Yoo-Na Kim, Yun Soo Chung, Eunhyang Park, Seung Tae Lee, Jung-Yun Lee
Sci Rep. 2024; 14: 7992. Published online 2024 Apr 5. doi: 10.1038/s41598-024-57515-y
PMCID:
PMC10997762
AbstractArticlePDF–2.2M
11.
Site-specific glycosylation analysis of epidermal growth factor receptor 2 (ErbB2): exploring structure and function toward therapeutic targeting
Naoki Fujitani, Yasuaki Uehara, Shigeru Ariki, Ukichiro Hashimoto, Jo Mukai, Yoshihiro Hasegawa, Motoko Takahashi
Glycobiology. 2024 Mar; 34(3): cwad100. Published online 2023 Dec 18. doi: 10.1093/glycob/cwad100
Correction in:
Glycobiology. 2024 May; 34(5): cwae018.
PMCID:
PMC10987295
AbstractArticlePDF–3.5M
12.
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression
Rui Kitadai, Tadaaki Nishikawa, Hiroshi Yoshida, Chiharu Mizoguchi, Kasumi Yamamoto, Tomoyasu Kato, Kan Yonemori
J Gynecol Oncol. 2024 Mar; 35(2): e11. Published online 2023 Oct 12. doi: 10.3802/jgo.2024.35.e11
PMCID:
PMC10948979
AbstractArticlePDF–7.1M
13.
Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma
Suzannah G. Miller, Maria Hoh, Christopher C. Ebmeier, Jian Wei Tay, Natalie G. Ahn
Mol Biol Cell. 2024 Mar 1; 35(3): ar31. Published online 2024 Jan 29. doi: 10.1091/mbc.E23-06-0255
PMCID:
PMC10916866
AbstractArticlePDF–4.7M
14.
Targeting HER2/HER3 co‐mutations in metastatic breast cancer: Case reports of exceptional responders to trastuzumab and pertuzumab therapy
Page E. Blas, Esther San Roman Rodriguez, Heather L. Williams, Maren K. Levin, Joshua S. K. Bell, Mariaelena Pierobon, Alexander S. Barrett, Emanuel F. Petricoin, Joyce A. O'Shaughnessy
Cancer Rep (Hoboken) 2024 Mar; 7(3): e1954. Published online 2024 Mar 5. doi: 10.1002/cnr2.1954
PMCID:
PMC10913072
AbstractArticlePDF–6.4M
15.
miRNA‐449c‐5p regulates the JAK‐STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting ERBB2
Li Li, Yangqiurong Zhang, Kunxian Yang, Wei Liu, Ziting Zhou, Ying Xu
Cancer Rep (Hoboken) 2024 Feb; 7(2): e1974. Published online 2024 Feb 13. doi: 10.1002/cnr2.1974
PMCID:
PMC10864726
AbstractArticlePDF–2.7M
16.
HER2-positive is an independent indicator for predicting pathological complete response to neoadjuvant therapy and Ki67-changed after neoadjuvant chemotherapy predicts favorable prognosis in Chinese women with locally advanced breast cancer
Yutong Fang, Qunchen Zhang, Yuan Wu, Jundong Wu
Medicine (Baltimore) 2024 Feb 9; 103(6): e37170. Published online 2024 Feb 9. doi: 10.1097/MD.0000000000037170
PMCID:
PMC10860946
AbstractArticlePDF–1.7M
17.
ERBB2‐amplified lobular breast carcinoma exhibits concomitant CDK12 co‐amplification associated with poor prognostic features
Miriam Forster‐Sack, Martin Zoche, Bernhard Pestalozzi, Isabell Witzel, Esther Irene Schwarz, Joel Julien Herzig, Hisham Fansa, Christoph Tausch, Jeff Ross, Holger Moch, Zsuzsanna Varga
J Pathol Clin Res. 2024 Mar; 10(2): e12362. Published online 2024 Jan 21. doi: 10.1002/2056-4538.12362
PMCID:
PMC10800294
AbstractArticlePDF–45M
18.
The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD‐L1 expression
Xiaoqian Jing, Zhiping Luo, Jiayan Wu, Feng Ye, Jianfang Li, Zijia Song, Yaqi Zhang, Minmin Shi, Huaibo Sun, Yi Fang, Yimei Jiang, Xiaopin Ji
Cancer Med. 2023 Dec; 12(24): 21905–21919. Published online 2023 Dec 5. doi: 10.1002/cam4.6765
PMCID:
PMC10757096
AbstractArticlePDF–2.2M
19.
Outcomes of advanced gastroesophageal cancer patients with equivocal HER2 expression with or without ERBB2 gene amplification
Ahmed Abdelhakeem, Xuemei Wang, Jane E. Rogers, Allison Trail, Meina Zhao, Mariela Blum-Murphy, J. S. Estrella, Jaffer A. Ajani
Oncology. Author manuscript; available in PMC 2023 Oct 27.
Published in final edited form as: Oncology. 2020; 98(12): 884–888. Published online 2020 Sep 30. doi: 10.1159/000509148
PMCID:
PMC10604547
AbstractArticlePDF–262K
20.
Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR
Cuiwei Liu, Chong Lu, Lamu Yixi, Jiaxing Hong, Fang Dong, Shengnan Ruan, Ting Hu, Xiangwang Zhao
Breast Cancer Res. 2023; 25: 124. Published online 2023 Oct 17. doi: 10.1186/s13058-023-01720-6
PMCID:
PMC10580635
AbstractArticlePDF–15M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center